Galectin Therapeutics (GALT) Minority Interest (2015 - 2016)
Galectin Therapeutics' (GALT) quarterly Minority Interest came in at $1.7 million in Q3 2016, little changed quarter-over-quarter from $1.7 million in Q2 2016.
Galectin Therapeutics (GALT) Minority Interest (2015 - 2016) Analysis & Trends
Galectin Therapeutics' Minority Interest history runs 2 years deep, the most recent figure standing at $1.7 million for Q3 2016.
- On a quarterly basis, Minority Interest changed N/A year-over-year to $1.7 million in Q3 2016; TTM through Sep 2016 was $1.7 million, a N/A change from a year earlier, with the FY2015 full-year figure at $1.7 million, changed N/A from the prior year.
- Minority Interest held at $1.7 million in Q3 2016 per GALT's latest filing, from $1.7 million in the prior quarter.
- Across five years, Minority Interest topped out at $1.7 million in Q4 2015 and bottomed at $1.7 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 1.72 Mn |
| Jun 30, 2016 | 1.72 Mn |
| Mar 31, 2016 | 1.72 Mn |
| Dec 31, 2015 | 1.72 Mn |